Vitro prediction of in vivo half-life
AssigneeHoffmann-La Roche Inc.
InventorsThomas Emrich, Hubert Kettenberger, Tilman Schlothauer, Angela Schoch
Life of this patent
Estimating the term…
Loading patent…
AssigneeHoffmann-La Roche Inc.
InventorsThomas Emrich, Hubert Kettenberger, Tilman Schlothauer, Angela Schoch
Estimating the term…
Herein is reported a method for determining the presence of antibody-Fab-FcRn interaction in an antibody-Fc-FcRn complex influencing the in vivo half-life comprising the steps of a) determining the retention time of the antibody on an FcRn affinity chromatography column with a positive linear pH gradient elution in the presence of a first sodium chloride concentration, and b) determining the retention time of the antibody on an FcRn affinity chromatography column with a positive linear pH gradient elution in the presence of a second sodium chloride concentration, whereby the presence of antibody-Fab-FcRn interaction in an antibody-Fc-FcRn complex influencing the in vivo half-life is determined if the retention time determined in step a) and the retention time determined in step b) are substantially different.
A method for selecting a variant antibody of a parent antibody, comprising the steps of:
Dependencies are inferred from the claim text.